Ikris Pharma
About Us Named Patient Program
Contact Us
Tezspire

Sourced directly from the authorized manufacturer network to ensure authenticity and quality.

You can also access detailed information by clicking Login in the website header.

Tezspire

Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.

Medicine Name: Tezspire
Generic Name (API): Tezepelumab
Dosage Form & Strength: 210 mg
Route: Subcutaneous injection
Drug Class: Thymic stromal lymphopoietin (TSLP) blocker (monoclonal antibody)

Manufacturer / Innovator:

Germany

Regulatory Approval:

  • US FDA
Family enjoying life with Named Patient Program access

Your Trustedworthy Partner For Named Patient Program

  • your trusted partner for named patient program

    Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.

  • 100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

    100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

  • Medicines sourced from authorized manufacturers with full batch traceability

    Medicines sourced from authorized manufacturers with full batch traceability.

  • EU-GDP Compliant Warehousing for secure, quality-controlled global distribution.

    EU-GDP compliant warehousing for secure, quality-controlled global distribution.

  • Temperature-Controlled Logistics for Safe and Timely Delivery

    Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.

GDP Compliant
Licensed Wholesale distributor

What Is Tezspire Used For?

Tezspire (tezepelumab-ekko) is a human monoclonal antibody that blocks thymic stromal lymphopoietin (TSLP), a key protein involved in airway inflammation. It is indicated for:

  • Add-on maintenance treatment of severe asthma in adult and pediatric patients 12 years of age and older

Tezspire is a prescription medicine and must be used under the supervision of a qualified pulmonologist or allergist. It is not intended for relief of acute bronchospasm or asthma exacerbations.

Recommended Dosage

  • 210 mg given by subcutaneous injection once every 4 weeks

This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.

Tezspire Warnings and Precautions

  • Not for acute symptoms: Tezspire should not be used to treat acute bronchospasm, status asthmaticus, or sudden asthma exacerbations.
  • Hypersensitivity reactions: Rash and allergic conjunctivitis can occur, sometimes with delayed onset of several days; Tezspire is contraindicated in patients with known hypersensitivity to it or its excipients.
  • Corticosteroid tapering: Systemic and inhaled corticosteroids should not be discontinued abruptly upon starting Tezspire; any dose reduction should be gradual and supervised by the treating doctor.

How to Access Tezspire in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Tezspire to India?

Tezspire (tezepelumab-ekko) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

  • A valid prescription from a qualified pulmonologist or allergist
  • The patient's diagnostic reports confirming severe asthma
  • Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Tezspire available in India?

Tezspire (tezepelumab-ekko injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Tezspire is not commercially marketed in India.

However, patients in India can legally access Tezspire through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Tezspire received US FDA approval in December 2021 for the add-on maintenance treatment of severe asthma, ensuring full transparency throughout the process.

Tezspire can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

For patients with severe asthma, NPP also facilitates access to Dupixent, another biologic option, based on the treating pulmonologist's assessment.

Sourcing & Delivery of Tezspire

Tezspire is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant, cold-chain logistics to preserve product integrity from dispatch to delivery.

  • Cold-chain shipping maintained at 2°C to 8°C throughout transit
  • Real-time shipment tracking and delivery updates
  • Delivery coordinated directly with the patient, family, or treating hospital

Availability of Tezspire Across Major Cities in India

Named Patient Program supports access to Tezspire for patients with severe asthma across major cities in India, coordinating documentation, sourcing, and delivery with treating pulmonologists.

Mumbai

Patients in Mumbai can access Tezspire through NPP with support from treating pulmonologists and allergists at the city's leading respiratory centers.

Delhi

In Delhi, NPP coordinates with hospitals and specialty respiratory clinics to facilitate timely access to Tezspire.

Bangalore

Bangalore's pulmonology and allergy centers work with NPP to support patients requiring Tezspire.

Chennai

Patients in Chennai can access Tezspire through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's respiratory disease centers support diagnosis and access coordination for Tezspire through NPP.

Kolkata

NPP facilitates access to Tezspire for patients in Kolkata under the guidance of treating pulmonologists.

Pune

Patients in Pune can access Tezspire through NPP with prescription-based coordination and cold-chain delivery support.

Ahmedabad

NPP supports access to Tezspire for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Tezspire through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Tezspire for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Tezspire through NPP with support from treating pulmonologists.

Lucknow

NPP facilitates access to Tezspire for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Tezspire through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Tezspire for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.

Written By:

Written By: Nitin Goswami, Senior Medical Content Writer
Last Updated: 09 September 2026
Sources: FDA • CDSCO

Medically Reviewed By:

Medically Reviewed By: Shilpi Banerjee, Registered Pharmacist (M.Pharm)
Last Updated: 09 September 2026

TRUSTED BY HEALTHCARE PROFESSIONALS & HOSPITALS

Need Help
Accessing Medicines?

Our specialists are here to guide you through every step of the medicine access process.

Let's us help!

Send us a message

Read how to access medicines

Read More arrow icon

Frequently Asked
Questions

Read More